Tumor flare pain reaction following bispecific T-Cell engagers in multiple myeloma: a unique and underrecognized toxicity - PubMed
3 hours ago
- #bispecific T-cell engager
- #toxicity
- #multiple myeloma
- Tumor flare pain reaction is identified as a toxicity following bispecific T-cell engager treatment in multiple myeloma.
- This reaction is characterized as a unique and underrecognized adverse event in clinical practice.
- The abstract highlights the need for increased awareness and recognition among healthcare providers.